Women’s Propet PedWalker 3PedWalker 3 Medicare/HCPCS code = A5500 Diabetic Shoe
$26.99
- Loaded with style and comfort, the PedWalker 3 is designed to keep you and your feet happy all day long.
- SKU: #8369362
- Smooth supple full grain leather & stretchable neoprene uppers.
- Stretchable neoprene is great for hammertoes and bunions.
- Features a single hook-and-loop strap closure in a blucher style.
- Offers a padded collar and tongue for added comfort.
- Soft and breathable leather and textile lining.
- Features double removable Propet Extra Volume insole system insoles perfect for customizing your level of comfort by removing one, both, none, or replacing them with your own custom orthotics.
- Lightweight EVA midsole for shock absorption.
- Rubber outsole.
- Medicare/HCPCS code = A5500 diabetic shoe.
- Imported.
- Product measurements were taken using size 8.5, width M (B). Please note that measurements may vary by size.
- Measurements:
- Heel Height: 1 in
- Weight: 8 oz
- Platform Height: 3⁄4 in
| Size | 12, 6.5 |
|---|
Be the first to review “Women’s Propet PedWalker 3PedWalker 3 Medicare/HCPCS code = A5500 Diabetic Shoe”
Related products
Sale!
Sandals
Original price was: $114.00.$79.99Current price is: $79.99.
Sandals
$22.89
Sale!
Sandals
Original price was: $26.00.$19.89Current price is: $19.89.
Sandals
$87.89
Sale!
Sandals
Original price was: $41.00.$28.99Current price is: $28.99.
Sale!
Sandals
Original price was: $50.00.$36.89Current price is: $36.89.
Sale!
Sandals
Original price was: $25.00.$18.99Current price is: $18.99.
Sale!
Sandals
Original price was: $40.00.$28.99Current price is: $28.99.
Sale!
Original price was: $29.00.$20.89Current price is: $20.89.
Sandals
$35.89
Sandals
$14.89
Sandals
$30.89
Sale!
Sandals
Original price was: $114.00.$75.99Current price is: $75.99.
Sale!
Sandals
Original price was: $34.00.$24.89Current price is: $24.89.
Sale!
Original price was: $59.00.$41.89Current price is: $41.89.
Sale!
Sandals
Original price was: $37.00.$27.89Current price is: $27.89.
Reviews
There are no reviews yet.